Financialsexperimental
LABCORP HOLDINGS INC. (LH). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
On 17 May 2024 this company filed a Form 8-K12B saying it is the successor issuer to an earlier registrant (for example after forming a new holding company or changing its domicile). Its statements from before then may be filed under that earlier company's CIK, which the filing names. Read the Form 8-K12B
USD in millions · per-share amounts in USD
| Income Statement | Q2 FY26 30 Jun 2026 | Q1 FY26 31 Mar 2026 | Q4 FY25 31 Dec 2025 | Q3 FY25 30 Sept 2025 | Q2 FY25 30 Jun 2025 | Q1 FY25 31 Mar 2025 | Q4 FY24 31 Dec 2024 | Q3 FY24 30 Sept 2024 | Q2 FY24 30 Jun 2024 | Q1 FY24 31 Mar 2024 | Q4 FY23 31 Dec 2023 | Q3 FY23 30 Sept 2023 | Q1 FY23 30 Jun 2023 | Q1 FY23 31 Mar 2023 | Q4 FY21 31 Dec 2022 | Q3 FY22 30 Sept 2022 | Q2 FY22 30 Jun 2022 | Q3 FY21 31 Mar 2022 | Q4 FY21 31 Dec 2021 | Q3 FY21 30 Sept 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3,731.1 | 3,537.6 | 3,515.8* | 3,563.5 | 3,527.3 | 3,345.1 | 3,329.4* | 3,282 | 3,220.9 | 3,176.6 | 3,033.3* | 3,056.8 | 3,033.7 | 3,777.9 | 3,674.2* | 3,606.1 | 3,696.9 | 3,899.6 | 4,056.1* | 4,062.6 |
| Cost of revenues | 2,619.1 | 2,523.8 | 2,522.6* | 2,538.4 | 2,481.1 | 2,397.1 | 2,433.1* | 2,377.6 | 2,294.5 | 2,279.3 | 2,211.9* | 2,205.6 | 2,191.5 | 2,803.2 | 2,704.4* | 2,546.4 | 2,574.2 | 2,666.7 | 2,681.1* | 2,677.1 |
| Gross profit | 1,112 | 1,013.8 | 993.2* | 1,025.1 | 1,046.2 | 948 | 896.3* | 904.4 | 926.4 | 897.3 | 821.4* | 851.2 | 842.2 | 974.7 | 969.8* | 1,059.7 | 1,122.7 | 1,232.9 | 1,375* | 1,385.5 |
| Selling, general, and administrative expenses | 577.2 | 551 | 538.6* | 552.4 | 579.3 | 546 | 595.2* | 568.6 | 557.8 | 508.4 | 532.9* | 525.5 | 505.8 | 553.6 | 536.5* | 510 | 486 | 464.1 | 543.7* | 519.9 |
| Amortization of intangibles and other assets | 78.1 | 75.6 | 72.6* | 69.5 | 68.3 | 69.6 | 70.4* | 63.7 | 62.2 | 60.1 | 59.2* | 55.7 | 51.5 | 69.3 | 60.6* | 65.2 | 66.4 | 67.1 | 92.9* | 92.2 |
| Restructuring and other charges | 5.1 | 6.4 | 5.9 | 4.1 | 6.4 | 11.4* | 18 | 11.6 | 5 | 18.3* | 7.5 | 15.8 | 8.6 | 11.7* | 15.1 | 44.4 | 12.6 | 7.8* | 6.5 | |
| Asset Impairment Charges | 3.6* | 0.7 | 0 | 0 | 2.8* | 0 | 0 | 2.5 | 10.2 | 2.8 | 2.2 | 0 | 0 | 1.2 | 0 | |||||
| Operating income | 451.6 | 380.8 | 267.6* | 396.6 | 394.5 | 326 | 216.5* | 254.1 | 294.8 | 321.3 | -122.8* | 252.3 | 266.3 | 341 | 90.7* | 469.4 | 525.9 | 687.9 | 730.6* | 766.9 |
| Interest expense | -61.1 | -55.1 | -55* | -56 | -57.1 | -56 | -63.4* | -50.4 | -47.6 | -46.9 | -48.8* | -50.3 | -49.8 | -50.7 | -49.3* | -46.3 | -42.5 | -42.2 | -43.1* | -42.2 |
| Investment income | 5.6 | 12.2 | 3.5* | 3.5 | 1.7 | 6.5 | 15* | 3.1 | 1.3 | 2.9 | 6.2* | 15.9 | 4.5 | 2.2 | 1.7* | 4.1 | 2 | 1.1 | 1.9* | 3.2 |
| Equity method loss, net | -6.2 | -5.1 | -6.1* | -5.2 | -1.7 | -0.3 | -0.7* | -0.5 | -0.3 | 0.1 | 0.1* | -0.3 | 0.9 | -2.1 | -1.1* | 1.7 | 1.4 | 3.4 | 5.6* | 8.4 |
| Other, net | -3.5 | -13.1 | -19.4* | -1.9 | -32.7 | -1 | 16.4* | 4.3 | 19.5 | 20 | 18.2* | 21.1 | -16.9 | -12.6 | 2.5* | -7.3 | -10.4 | -10.1 | -9* | 31.9 |
| Earnings from operations before income taxes | 386.4 | 319.7 | 190.6* | 337 | 304.7 | 275.2 | 183.8* | 210.6 | 267.7 | 297.4 | -147.1* | 238.7 | 205 | 277.8 | 421.6 | 476.4 | 640.1 | 768.2 | ||
| Provision for income taxes | 87.3 | 41.7 | 25.7* | 75.5 | 66.4 | 62.2 | 40.2* | 41 | 62.1 | 69.1 | 19.7* | 55.1 | 49.8 | 64.5 | -31.9* | 68.4 | 117.5 | 148 | 132.4* | 180.4 |
| Net earnings | 299.1 | 278 | 164.9* | 261.5 | 238.3 | 213 | 143.6* | 169.6 | 205.6 | 228.3 | -166.8* | 183.6 | 189.1 | 213.3 | 76.4* | 353.2 | 358.9 | 492.1 | 553.6* | 587.8 |
| Less: Net earnings attributable to the noncontrolling interest | -0.4 | -0.2 | -0.2* | -0.4 | -0.4 | -0.2 | -0.2* | -0.3 | -0.3 | -0.3 | -0.3* | -0.3 | -0.2 | -0.4 | -0.3* | -0.4 | -0.3 | -0.5 | -0.6* | -0.5 |
| Earnings from continuing operations | 143.6* | 169.6 | 205.6 | 228.3 | -166.8* | 183.6 | 155.2 | |||||||||||||
| Net earnings attributable to Labcorp Holdings Inc. | 298.7 | 277.8 | 164.7* | 261.1 | 237.9 | 212.8 | 143.4* | 169.3 | 205.3 | 228 | -167.1* | 183.3 | 188.9 | 212.9 | 76.1* | 352.8 | 358.6 | 491.6 | 553* | 587.3 |
| Earnings from discontinued operations, net of tax | 0* | 0 | 0 | 0 | 0* | 0 | 33.9 | |||||||||||||
| Basic earnings per share (in dollars per share) | 3.66 | 3.37 | 3.14 | 2.85 | 2.54 | 2.02 | 2.44 | 2.71 | 2.12 | 2.13 | 2.41 | 3.91 | 3.89 | 5.27 | 6.1 | |||||
| Diluted earnings per share (in dollars per share) | 3.64 | 3.35 | 3.12 | 2.84 | 2.52 | 2 | 2.43 | 2.69 | 2.11 | 2.12 | 2.39 | 3.9 | 3.87 | 5.23 | 6.05 | |||||
| Basic earnings per share from continuing operations | 2.02 | 2.44 | 2.71 | 2.12 | 1.75 | |||||||||||||||
| Basic earnings per share from discontinued operations | 0 | 0 | 0 | 0 | 0.38 | |||||||||||||||
| Diluted earnings per share from continuing operations | 2 | 2.43 | 2.69 | 2.11 | 1.74 | |||||||||||||||
| Diluted earnings per share from discontinued operations | 0 | 0 | 0 | 0 | 0.38 |